|
41
|
FDA |
Off-The-Shelf Software Use in Medical Devices - Guidance for Industry and Food and Drug Administration Staff, 2019.
|
|
42
|
FDA |
Content of Premarket Submissions for Management of Cybersecurity in Medical Devices - Draft Guidance for Industry and Food and Drug Administration Staff, 2018
|
|
43
|
FDA |
Postmarket Management of Cybersecurity in Medical Devices, 2016
|
|
44
|
FDA |
Content of Premarket Submissions for Management of Cybersecurity in Medical Devices - Guidance for Industry and Food and Drug Administration Staff, 2014
|
|
45
|
FDA |
General Principles of Software Validation: Guidance for Industry and FDA Staff, 2002.
|
|
46
|
EU |
(EU)General leaflet ATI Policy Brief reports, 2021
|
|
47
|
EU |
(EU)Advanced technology landscape and related policies in China, 2021
|
|
48
|
EU |
(EU)proposal-for-a-regulation-laying-down-harmonised-rules-on-artificial-intelligence-impact-on-the-healthcare-sector-and-the-medical-device-industry, 2021
|
|
49
|
EU |
(EU)Advanced Technologies for Industry – Product Watch_Artificial Intelligence-based software as a medical device, 2020
|
|
50
|
EU |
(EU)Guidlines on the Quilification and Classification of Stand Alone Software Used in Healthcare within the Regulatory Framework of Medical Deivces, 2020
|
